A new study describes a biomarker profile based on cerebrospinal fluid (CSF) tau and amyloid-β₁₋₄₂ in a uniquely large population with a variety of dementia diagnoses. This study confirms the differential diagnostic value of CSF biomarkers and further highlights the important neuropathological overlap between dementia aetiologies.